Antiviral Chemotherapy 4 New Directions for Clinical Application and Research / edited by John Mills, Paul A. Volberding, Lawrence Corey.
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed...
Full description
Saved in: